Search Results For ''

  • Fully clothed soccer mum baffled by her lack of OnlyFans subscribers

    As an elite stay at home mum whose cookies are the envy of the Parent-Teachers Association, Martina Martinez drew on her entrepreneurial spirit by starting an OnlyFans account, posting photos of her cookies.  Much to her surprise however, paying subscribers to her channel have been few and far between with Martinez confused as to why

    Read More
    Public
  • Yep, cannabis-infused beer is a thing and Althea is brewing it in Canada

    The ever progressive Canadians just know how to have fun which is just one reason cannabis-infused beverages are proving a major hit in the Great White North. Seeking to capitalising on this trend is medicines and recreational cannabis company Althea (ASX: AGH) which has partnered with beer giant The Boston Beer Company (NYSE: SAM) to

    Read More
    Public
  • 4DMedical’s clinical pilot program to progress following successful first phase

    Following a particularly well received first phase of their clinical pilot program, medical technology company 4DMedical (ASX: 4DX) is advancing their respiratory imaging platform to Phase 2 of their clinical pilot program. Conducted with Australia’s leading medical imaging provider, I-MED Radiology Network, Phase 1 of the program saw radiologists use 4DMedical’s proprietary XV Lung Ventilation

    Read More
    Public
  • The heroes of the reporting season

    For a profit reporting season that promised the first bloom of earnings recovery, August’s slew of disclosures lacked a bit of froth and bubble. The numbers themselves were ok, in the context of earnings rebounding from the Covid year But the outlook statements were unconvincing and investors had largely factored in the historical numbers. On

    Read More
    Public
  • A step closer towards scarless wound healing: Pharmaxis drug through Phase 1 trial

    Whilst key opinion leaders worldwide are following the Pharmaxis (ASX: PXS) story, Professor Fiona Wood has become an integral part of it.  Following the news out of Rochester University that their myelofibrosis drug, PXS-5505, has a potential significant disease modifying role in other cancers comes another key announcement for the company, this time regarding theirRead More
    Public
  • Investing in local tech jobs, Novatti revenues jump 55% on digital payments growth

    As the world circles Australia’s thriving fintech industry which produced the largest takeover in Australian history, digital payments company Novatti Group (ASX: NOV) is staking its claim as a rising star on the global stage which has seen its revenue jump 55% amid a recent hiring spree. Although they are not as well known as

    Read More
    Public